Faron is planning for a Phase III trial, pending U.S Food and Drug Administration (FDA) End of Phase II meeting Feedback TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON ...

TURKU, FI / ACCESS Newswire / March 27, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) New analysis and biomarker data strengthens understanding of bexmarilimab's potential TURKU, FINLAND ...

TURKU, FI / ACCESS Newswire / April 15, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Inside Information: BEXMAB Phase II trial met its primary endpoint in treatment-resistant High Risk MDS ...

With a national ban increasingly unlikely, let’s reflect on how the app both sparks joy among users and raises mental health concerns. By Brian X. Chen Brian X. Chen is The Times’s lead ...

President Donald Trump has for a second time extended the deadline that would have required TikTok to be sold or face a ban in the US. A bipartisan law passed by Congress last year mandates TikTok ...

Faron is planning for a Phase III trial, pending U.S Food and Drug Administration (FDA) End of Phase II meeting Feedback TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a ...

Faron Pharmaceuticals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive phase 2 interim data from Bexmab trial at the annual meeting of the ...